SCHEMBL3018934

SCHEMBL3018934

COc1ccccc1Cc1csc(N2CCC(S(=O)(=O)c3cc(Cl)ccc3OC)CC2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.40
ADRA1D P25100 3/20 0.40
ADRA1A P35348 3/20 0.40
ADRA1B P35368 3/20 0.40
TP53 P04637 3/20 0.39
ALDH1A1 P00352 3/20 0.39
POLB P06746 2/20 0.39
RAB9A P51151 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
MAPK1 P28482 1/20 0.38
TSHR P16473 3/20 0.38
MAPT P10636 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.37
NPC1 O15118 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
HTR7 P34969 1/20 0.37
ALPL P05186 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3002832 0.94 TP53 (0.38) DRD2ADRA1DADRA1AADRA1BTP53
SCHEMBL3007050 0.93 MAPK1 (0.39) DRD2ADRA1DADRA1AADRA1BTP53
SCHEMBL3012653 0.92 MEN1 (0.37) DRD2ADRA1DADRA1AADRA1BTP53
SCHEMBL3007108 0.91 TDP1 (0.42) DRD2ADRA1DADRA1AADRA1BTP53
SCHEMBL3011978 0.91 ALDH1A1 (0.44) ALDH1A1POLBRAB9AKDM4EHPGD
SCHEMBL3002108 0.90 ALDH1A1 (0.39) TP53ALDH1A1POLBRAB9AKDM4E
SCHEMBL3015530 0.90 DRD2 (0.40) DRD2ADRA1DADRA1AADRA1BALDH1A1
SCHEMBL3002902 0.90 TP53 (0.41) TP53ALDH1A1POLBRAB9AKDM4E
SCHEMBL3016060 0.90 RAB9A (0.38) DRD2ADRA1DADRA1AADRA1BTP53
SCHEMBL3011425 0.90 MAPT (0.39) TP53ALDH1A1POLBRAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722681-B2 N-sulfonyl thiazolylpiperazine derivatives and related N-sulfonyl heterocyclic derivatives for the treatment of neuro degenerative diseases NV REMYND (BE) 2014-05-13 US disclosed
US-20100197703-A1 N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES NV REMYND (BE) 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197703-A1 N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES SMN1; SMN2, HTT, SNCA DRD2 573/4885ADRA1D 895/4885ADRA1A 1454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.